Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Pfizer Too Dependent on COVID-19 Revenue?

TheMotleyFool

0 0

Is Pfizer Too Dependent on COVID-19 Revenue?: https://g.foolcdn.com/editorial/images/677207/a-team-of-scientists-reviewing-results-in-a-lab.jpg

Pfizer (NYSE: PFE) released its first-quarter results this week. The numbers were strong as the company beat analyst expectations for both revenue and earnings. Unsurprisingly, COVID-19 revenue from its vaccine and pill drove a lot of the growth for the business. Pfizer reaffirmed its forecast of $54 billion in revenue from those two products alone.

But what else is generating meaningful growth for the healthcare company? And is Pfizer too dependent on revenue from its COVID-19 vaccine and pill? Here's a quick look at its top products from the past quarter.

Image source: Getty Images.

Source Fool.com

Like: 0

PFE

Share